<DOC>
	<DOCNO>NCT00504023</DOCNO>
	<brief_summary>RATIONALE : Biological therapy , imiquimod , may stimulate immune system different way stop tumor cell grow . Applying topical imiquimod vulva may effective treatment recurrent Paget 's disease . PURPOSE : This clinical trial study well topical imiquimod work treat patient recurrent Paget 's disease vulva .</brief_summary>
	<brief_title>Topical Imiquimod Treating Patients With Recurrent Paget 's Disease Vulva</brief_title>
	<detailed_description>OBJECTIVES : - To assess clinical histologic effect topical imiquimod therapy recurrent extramammary Paget 's disease . OUTLINE : This pilot , prospective , multicenter study . Patients apply topical imiquimod cream target vulvar lesion 3 time weekly . Treatment continue 12 week absence disease progression unacceptable toxicity . If lesion still present completion 12 week imiquimod therapy , patient undergoes surgical excision target lesion ( progressive lesion suspicious evolve adenocarcinoma ) week 16 . Patients undergo punch biopsy photographic assessment target vulvar lesion baseline 12 week . After completion imiquimod therapy surgical excision , patient follow 6 week every 3 month least 2 year .</detailed_description>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>All patient present Gynecology outpatient service participate institution meet eligibility requirement may include clinical trial . The eligibility requirement follow : Age â‰¥18 . Ability give inform consent . Patients must biopsy proven recurrent extramammary Paget 's disease confirm participate site . Patients know hypersensitivity imiquimod . Pregnant nursing woman eligible Patients underlie adenocarcinoma biopsy lesion confirm participate site .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Paget disease vulva</keyword>
	<keyword>recurrent vulvar cancer</keyword>
	<keyword>stage 0 vulvar cancer</keyword>
	<keyword>stage I vulvar cancer</keyword>
	<keyword>stage II vulvar cancer</keyword>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>imiquimod</keyword>
	<keyword>07-029</keyword>
</DOC>